Vergoeding 2020-2024 voor ATC-subgroep A10B : Bloedglucoseverlagende middelen excl. insulines

  • Raming voor de totale Zvw-populatie
  2020 2021 2022 2023 2024
A10BA Biguaniden 10.353.400 12.048.000 12.339.900 14.324.100 16.634.100
A10BB Sulfonylureumderivaten 8.875.300 10.602.100 10.961.000 14.629.300 16.484.800
A10BD Combinaties van bloedglucoseverlagende middelen 3.630.300 3.518.700 3.544.800 3.000.700 2.484.300
A10BF Alfa-glucosidaseremmers 109.760 95.128 81.052 36.823 17.600
A10BG Thiazolidinedionen 61.009 83.232 298.580 395.560 399.470
A10BH Dipeptidylpeptidase-4-remmers 15.614.900 15.208.700 15.482.500 12.249.200 10.227.400
A10BJ Glucagonachtig peptide-1-agonisten (glp-1-agonisten) 40.054.500 50.379.200 80.495.200 117.354.500 149.715.500
A10BK Natriumglucose-cotransporter-2-remmers (sglt-2-remmers) 7.384.800 10.195.300 34.366.200 62.610.800 90.093.800
A10BX Overige bloedglucoseverlagende middelen excl. insulines 54.144 51.168 49.716 46.329 937.080
Totaal 86.138.113 102.181.528 157.618.948 224.647.312 286.994.050